Compatibility and stability of the investigational polypeptide marine anticancer agent kahalalide F in infusion devices
Changes in prostate-specific antigen (PSA) level correlate with growth inhibition of prostate cancer cells treated in vitro with a novel anticancer drug, irofulven
Gene expression profiling of exposure to TZT-1027, a novel microtubule-interfering agent, in non-small cell lung cancer PC-14 cells and astrocytes
A phase I trial of the oral platinum analogue JM216 with concomitant radiotherapy in advanced malignancies of the chest
Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck : A Southwest Oncology Group Phase II Study
Phase II trial of irofulven (6-hydroxymethylacylfulvene) for patients with advanced Renal cell carcinoma
Phase II trial of 9-aminocamptothecin as a 72-h infusion in cutaneous T-cell lymphoma
Phase II study of pyrazoloacridine in metastatic renal cell carcinoma
A phase II trial of 9-aminocaptothecin (9-ACrpar; as a 120-h infusion in patients with non-small cell lung cancer
Dolastatin-10 in metastatic melanoma : A phase II and pharmokinetic trial of the california cancer consortium
Therapeutic response to octreotide in patients with refractory CPT-11 induced diarrhea
Volume Contents
Author Index